LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹32 Cr | ₹57 Cr | ₹82 Cr | ₹69 Cr | ₹19 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of LAURUS LABS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹32 Cr |
| Mar2024 | ₹57 Cr |
| Mar2023 | ₹82 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹19 Cr |
How is Deferred Tax Assets / Liabilities of LAURUS LABS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹32 Cr | -44.13 | |
| Mar2024 | ₹57 Cr | -30.82 | |
| Mar2023 | ₹82 Cr | 19.30 | |
| Mar2022 | ₹69 Cr | 260.32 | |
| Mar2021 | ₹19 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹57,496.7 Cr | 3.4% | 15% | 100% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,531.0 Cr | 1.3% | 8.9% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,989.0 Cr | 2.4% | 6% | 12.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,936.0 Cr | -0.6% | 9.4% | 44.1% | Stock Analytics | |
| CIPLA | ₹109,200.0 Cr | 1.9% | 2% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,057.0 Cr | -0.4% | 9.5% | 10.5% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | 3.4% |
15% |
100% |
| SENSEX | -3.7% |
-2.5% |
6.5% |
You may also like the below Video Courses